BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology. 2020;72:287-304. [PMID: 32298473 DOI: 10.1002/hep.31281] [Cited by in Crossref: 164] [Cited by in F6Publishing: 206] [Article Influence: 82.0] [Reference Citation Analysis]
Number Citing Articles
1 Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol 2021; 27(44): 7625-7648 [PMID: 34908803 DOI: 10.3748/wjg.v27.i44.7625] [Reference Citation Analysis]
2 Merola J, Schilsky ML, Mulligan DC. The Impact of COVID-19 on Organ Donation, Procurement and Liver Transplantation in the United States. Hepatol Commun. 2020;. [PMID: 33043228 DOI: 10.1002/hep4.1620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat 2021. [PMID: 34352133 DOI: 10.1111/jvh.13590] [Reference Citation Analysis]
4 Serper M, Shaked A, Olthoff KM, Hoteit M, Appolo B, Reddy KR. A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities. J Hepatol 2020;73:708-9. [PMID: 32450089 DOI: 10.1016/j.jhep.2020.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
5 Pahari H, Shellagi N, Nath B. Deceased Donor Liver Transplantation in India in the COVID-19 Era: Current Scenario and Future Perspectives. Transplant Proc 2020;52:2684-7. [PMID: 32620390 DOI: 10.1016/j.transproceed.2020.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dumortier J, Duvoux C, Roux O, Altieri M, Barraud H, Besch C, Caillard S, Coilly A, Conti F, Dharancy S, Durand F, Francoz C, Garaix F, Houssel-Debry P, Kounis I, Lassailly G, Laverdure N, Leroy V, Mallet M, Mazzola A, Meunier L, Radenne S, Richardet JP, Vanlemmens C, Hazzan M, Saliba F; French Solid Organ Transplant COVID Registry., Groupe de Recherche Français en Greffe de Foie (GReF²). Covid-19 in liver transplant recipients: the French SOT COVID registry. Clin Res Hepatol Gastroenterol 2021;45:101639. [PMID: 33636654 DOI: 10.1016/j.clinre.2021.101639] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
7 Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S, Rossi M, Lerut J. SARS-CoV2 and immunosuppression: A double-edged sword. Transpl Infect Dis 2020;22:e13404. [PMID: 32639598 DOI: 10.1111/tid.13404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
9 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Hutchison AL, Pillai A. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant 2021;26:339-45. [PMID: 33938470 DOI: 10.1097/MOT.0000000000000883] [Reference Citation Analysis]
11 Altamimi E. Effect of COVID-19 Pandemic and Lockdown on Children With Gastrointestinal Disorders. Gastroenterology Res 2020;13:125-8. [PMID: 32655731 DOI: 10.14740/gr1290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kemme S, Yoeli D, Sundaram SS, Adams MA, Feldman AG. Decreased access to pediatric liver transplantation during the COVID-19 pandemic. Pediatr Transplant 2021;:e14162. [PMID: 34633127 DOI: 10.1111/petr.14162] [Reference Citation Analysis]
13 Sriram K, Loomba R, Insel PA. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. Proc Natl Acad Sci U S A 2020;117:29274-82. [PMID: 33203679 DOI: 10.1073/pnas.2009875117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ponziani FR, Aghemo A, Cabibbo G, Masarone M, Montagnese S, Petta S, Russo FP, Lai Q; AISF COVID-19 survey group. Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey. Liver Int 2021;41:2228-32. [PMID: 34219343 DOI: 10.1111/liv.14998] [Reference Citation Analysis]
15 Rao A, Puertolas M, Runde J. COVID-19 and Gastrointestinal and Hepatobiliary Diseases. Pediatr Ann 2021;50:e315-9. [PMID: 34398713 DOI: 10.3928/19382359-20210721-02] [Reference Citation Analysis]
16 Zelman, S. M.H., Erik MD1; Malik, Raza MD1; Dickstein, Aaron MD, Alcoholic Hepatitis and COVID-19: The Question of Steroids.ACG Case Rep J. 2020;7:e00504. [DOI: 10.14309/crj.0000000000000504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
19 Mehta N, Parikh ND, Kelley RK, Hameed B, Singal AG. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic. Clin Gastroenterol Hepatol 2021;19:1520-30. [PMID: 32652308 DOI: 10.1016/j.cgh.2020.06.072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Clark R, Waters B, Stanfill AG. Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments.Nurse Pract. 2021;46:21-26. [PMID: 33332825 DOI: 10.1097/01.NPR.0000722316.63824.f9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
22 Polak WG, Fondevila C, Karam V, Adam R, Baumann U, Germani G, Nadalin S, Taimr P, Toso C, Troisi RI, Zieniewicz K, Belli LS, Duvoux C. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry. Transpl Int. 2020;33:1244-1252. [PMID: 32609908 DOI: 10.1111/tri.13680] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
23 Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, Lund JL, Moon AM, Pate V, Barnes EL, Schlusser CL, Baron TH, Shaheen NJ, Sandler RS. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology 2021:S0016-5085(21)03655-6. [PMID: 34678215 DOI: 10.1053/j.gastro.2021.10.017] [Reference Citation Analysis]
24 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
26 Gonzalez AJ, Kapila N, Thomas E, Pinna A, Tzakis A, Zervos XB. Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States. World J Hepatol 2021; 13(12): 2161-2167 [DOI: 10.4254/wjh.v13.i12.2161] [Reference Citation Analysis]
27 Hakeem AR, Padmanaban H, Karthikeyan S, Murugesan S, Menon J, Shanmugam N, Jothimani D, Reddy MS, Rela M. Awareness and Concerns Among Adult Liver Transplant Recipients in the Current Pandemic Caused by Novel Coronavirus (COVID-19): Strategies to Safeguard a High-risk Population. J Clin Exp Hepatol 2020;10:540-7. [PMID: 32837094 DOI: 10.1016/j.jceh.2020.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Bhoori S, Rossi RE, Citterio D, Mazzaferro V. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol Hepatol. 2020;5:532-533. [PMID: 32278366 DOI: 10.1016/s2468-1253(20)30116-3] [Cited by in Crossref: 148] [Cited by in F6Publishing: 94] [Article Influence: 74.0] [Reference Citation Analysis]
29 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Huang CF, Wu PF, Yeh ML, Huang CI, Liang PC, Hsu CT, Hsu PY, Liu HY, Huang YC, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML. Scaling up the in-hospital hepatitis C virus care cascade in Taiwan. Clin Mol Hepatol 2021;27:136-43. [PMID: 33317253 DOI: 10.3350/cmh.2020.0150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK. Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis. Hepatology 2021;73:1521-30. [PMID: 32692464 DOI: 10.1002/hep.31472] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
32 Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, She ZG, Zhou J, Wang H, Lin J, Luo P, Fu S, Ye P, Xiao B, Mao W, Liu L, Yan Y, Chen G, Huang X, Zhang BH, Yuan Y. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020;72:389-398. [PMID: 32359177 DOI: 10.1002/hep.31301] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 65.5] [Reference Citation Analysis]
33 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cottone C, Pena Polanco NA, Bhamidimarri KR. Transplant of Elderly Patients: Is There an Upper Age Cutoff? Clin Liver Dis 2021;25:209-27. [PMID: 33978580 DOI: 10.1016/j.cld.2020.09.001] [Reference Citation Analysis]
35 Gatellier L, Shankar A, Dewi LKM, Hussain QM, Dendup Wangdi T, Sukumaran DB, Sari NK, Tavakkoli Shiraji S, Biglari M, Tahmasebi M, Iwata S, Suzuki T, Myung SK, Chun JY, Han JS, Lau FN, Yusak S, Bayarsaikhan L, Mu KT, Pradhananga KK, Yusuf A, Lin CH, Chiang RC, Sangrajran S, Nguyen QT, Huong GN, Soe AN, Sharma DN, Sengar M, Pramesh CS, Matsuda T, Jarrahi AM, Hwang W. The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres. Asian Pac J Cancer Prev 2021;22:681-90. [PMID: 33773529 DOI: 10.31557/APJCP.2021.22.3.681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kapuria D, Bollipo S, Rabiee A, Ben-Yakov G, Kumar G, Siau K, Lee HW, Congly S, Turnes J, Dhanasekaran R, Lui RN; Global Online Alliance for Liver Studies (GOAL). Roadmap to resuming care for liver diseases after coronavirus disease-2019. J Gastroenterol Hepatol 2021;36:885-92. [PMID: 32656794 DOI: 10.1111/jgh.15178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
38 Soin AS, Choudhary NS, Yadav SK, Saigal S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Mohan N, Saha SK, Gupta A, Chaudhary RJ, Yadav K, Dhampalwar S, Govil D, Gupta N, Vohra V. Restructuring Living Donor Liver Transplantation at a High Volume Center During the COVID-19 Pandemic. J Clin Exp Hepatol. 2020;. [PMID: 33052181 DOI: 10.1016/j.jceh.2020.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 Müller H, Kniepeiss D, Stauber R, Schrem H, Rauter M, Krause R, Schemmer P. Recovery from COVID-19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation. Am J Transplant 2020;20:3255-6. [PMID: 32492753 DOI: 10.1111/ajt.16107] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
40 Ono SK, Andraus W, Terrabuio DRB, Cobello-Júnior V, Arai L, Ducatti L, Haddad LBP, D'Albuquerque LAC, Carrilho FJ. Technological Innovation in Outpatient Assistance for Chronic Liver Disease and Liver Transplant Patients During the Coronavirus Disease Outbreak: A Method to Minimize Transmission. Clinics (Sao Paulo) 2020;75:e1946. [PMID: 32490936 DOI: 10.6061/clinics/2020/e1946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Aleem A, Mahadevaiah G, Shariff N, Kothadia JP. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness. Proc (Bayl Univ Med Cent) 2021;34:473-7. [PMID: 34219928 DOI: 10.1080/08998280.2021.1885289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol 2021; 27(12): 1117-1131 [PMID: 33828389 DOI: 10.3748/wjg.v27.i12.1117] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
43 Fung BM, Perumpail M, Patel YA, Tabibian JH. Telemedicine in Hepatology: Current Applications and Future Directions. Liver Transpl 2021. [PMID: 34506686 DOI: 10.1002/lt.26293] [Reference Citation Analysis]
44 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Da BL, Ezaz G, Kushner T, Crismale J, Kakked G, Gurakar A, Dieterich D, Schiano TD, Saberi B. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation. JAMA Netw Open 2020;3:e2027551. [PMID: 33275155 DOI: 10.1001/jamanetworkopen.2020.27551] [Reference Citation Analysis]
46 Jha SK, Jamir I, Sisodia K, Kumar N, Sood G, Shanker N, Anand S, Dubey G, Choudhary V, Lohia P, Singhal A, Wadhawan M, Kumar A, Chaudhary A. Restarting LDLT During COVID-19: Early Results After Restructuring. Transplant Proc 2021;53:1118-25. [PMID: 33478744 DOI: 10.1016/j.transproceed.2020.10.049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Goff RR, Wilk AR, Toll AE, McBride MA, Klassen DK. Navigating the COVID-19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States. Am J Transplant 2021;21:2100-12. [PMID: 33244847 DOI: 10.1111/ajt.16411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
48 Vuppalanchi V, Gelow K, Green K, Vuppalanchi R, Lammert C. Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic. J Investig Med 2021:jim-2021-001871. [PMID: 34315800 DOI: 10.1136/jim-2021-001871] [Reference Citation Analysis]
49 Fancellu A, Sanna V, Scognamillo F, Feo CF, Vidili G, Nigri G, Porcu A. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World J Clin Cases 2021; 9(15): 3517-3530 [PMID: 34046452 DOI: 10.12998/wjcc.v9.i15.3517] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 2020;22:e13427. [PMID: 32779820 DOI: 10.1111/tid.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
51 Jaduan SS, Singh SA, Madan K, Gupta S. SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? J Clin Exp Hepatol 2021. [PMID: 34305351 DOI: 10.1016/j.jceh.2021.07.005] [Reference Citation Analysis]
52 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
53 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
54 Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;21:100267. [PMID: 33053426 DOI: 10.1016/j.aohep.2020.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
55 Mangioni D, Dondossola D, Antonelli B, Alagna L, Invernizzi F, Polli F, Tosetti G, Muscatello A, Gori A, Rossi G. Coronavirus disease 2019 and transplantation: tackling the challenges of SARS-CoV-2 infection in waiting list candidates. Transpl Int 2020;33:1830-2. [PMID: 32936963 DOI: 10.1111/tri.13742] [Reference Citation Analysis]
56 Lobritto S, Danziger-Isakov L, Michaels MG, Mazariegos GV. Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs. Front Pediatr 2020;8:612627. [PMID: 33363069 DOI: 10.3389/fped.2020.612627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231-1240. [PMID: 32553666 DOI: 10.1016/j.jhep.2020.06.006] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 61.0] [Reference Citation Analysis]
58 Reddy KR. SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections. Clin Liver Dis (Hoboken) 2020;15:191-4. [PMID: 32489654 DOI: 10.1002/cld.970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
59 Zhou F, Xia J, Yuan HX, Sun Y, Zhang Y. Liver injury in COVID-19: Known and unknown. World J Clin Cases 2021; 9(19): 4980-4989 [PMID: 34307548 DOI: 10.12998/wjcc.v9.i19.4980] [Reference Citation Analysis]
60 Mandal A, Konala VM, Adapa S, Naramala S, Gayam V. Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications. Cureus. 2020;12:e8750. [PMID: 32714688 DOI: 10.7759/cureus.8750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
61 Alattar RA, Shaar SH, Othman M, Abu Jarir SH, Hashim SM, Iqbal F, Rustom F, Almaslamani MA, Omrani AS. Coronavirus disease 2019 in solid organ transplant recipients in the setting of proactive screening and contact tracing of Qatar. Qatar Med J 2021;2021:23. [PMID: 34604011 DOI: 10.5339/qmj.2021.23] [Reference Citation Analysis]
62 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]
63 Varma S, Pandey Y, Chikkala BR, Acharya R, Verma S, B I, Sreekumar S, Das D, Dey R, Agarwal S, Gupta S. Protocol to ensure continued pediatric liver transplantation service during the COVID pandemic and the encouraging outcomes. Pediatr Transplant. 2021;25:e13991. [PMID: 33704869 DOI: 10.1111/petr.13991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Steinack C, Hage R, Benden C, Schuurmans M. SARS-CoV-2 and Norovirus Co-Infection after Lung Transplantation. Transplantology 2020;1:16-23. [DOI: 10.3390/transplantology1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Delman AM, Turner KM, Jones CR, Vaysburg DM, Silski LS, King C, Luckett K, Safdar K, Quillin RC 3rd, Shah SA. Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic. Surgery 2021;169:1519-24. [PMID: 33589248 DOI: 10.1016/j.surg.2020.12.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Forns X, Navasa M. Liver transplant immunosuppression during the covid-19 pandemic. Gastroenterol Hepatol 2020;43:457-63. [PMID: 32646657 DOI: 10.1016/j.gastrohep.2020.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
67 MacConmara M, Wang B, Patel MS, Hwang CS, DeGregorio L, Shah J, Hanish SI, Desai D, Lynch R, Tanriover B, Zeh H 3rd, Vagefi PA. Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19. Ann Surg 2021;274:427-33. [PMID: 34183513 DOI: 10.1097/SLA.0000000000004994] [Reference Citation Analysis]
68 Hayashi K, Ito Y, Yamane R, Yoshizaki M, Matsushita K, Kajikawa G, Kozawa T, Mizutani T, Shimizu Y, Nagano K, Tachi K, Yoshioka K, Goto H. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome. Clin J Gastroenterol 2021;14:842-5. [PMID: 33675512 DOI: 10.1007/s12328-021-01374-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
70 Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022; 10(4): 1140-1163 [DOI: 10.12998/wjcc.v10.i4.1140] [Reference Citation Analysis]
71 Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. 2020;19:353-358. [PMID: 32425991 DOI: 10.1016/j.aohep.2020.05.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
72 Farshidpour M, Kim D, Junna S, Merchant J. A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic. Indian J Gastroenterol 2020;39:232-5. [PMID: 32621206 DOI: 10.1007/s12664-020-01068-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Wang J, Lu Z, Jin M, Wang Y, Tian K, Xiao J, Cai Y, Wang Y, Zhang X, Chen T, Yao Z, Yang C, Deng R, Zhong Q, Deng X, Chen X, Yang XP, Wei G, Wang Z, Tian J, Chen XP. Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study. Front Med 2021. [PMID: 34387851 DOI: 10.1007/s11684-021-0854-5] [Reference Citation Analysis]
74 Yang HY, Jin B, Mao YL. Liver injury in COVID-19: What do we know now? Hepatobiliary Pancreat Dis Int. 2020;19:407-408. [PMID: 32753332 DOI: 10.1016/j.hbpd.2020.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Alconchel F, Cascales-Campos PA, Pons JA, Martínez M, Valiente-Campos J, Gajownik U, Ortiz ML, Martínez-Alarcón L, Parrilla P, Robles R, Sánchez-Bueno F, Moreno S, Ramírez P. Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports. World J Hepatol 2020; 12(10): 870-879 [PMID: 33200024 DOI: 10.4254/wjh.v12.i10.870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Abolghasemi S, Mardani M, Sali S, Honarvar N, Baziboroun M. COVID-19 and kidney transplant recipients. Transpl Infect Dis 2020;22:e13413. [PMID: 32677721 DOI: 10.1111/tid.13413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Mori M, Ikeda N, Taketomi A, Asahi Y, Takesue Y, Orimo T, Ono M, Kuwayama T, Nakamura S, Yamada Y, Kuroda T, Yuzawa K, Hibi T, Nagano H, Unno M, Kitagawa Y. COVID-19: clinical issues from the Japan Surgical Society. Surg Today 2020;50:794-808. [PMID: 32651686 DOI: 10.1007/s00595-020-02047-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
78 Arrese M. Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology. Ann Hepatol 2020;19:339-40. [PMID: 32482463 DOI: 10.1016/j.aohep.2020.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Reference Citation Analysis]
80 Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR. How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? Front Med (Lausanne) 2020;7:398. [PMID: 32754608 DOI: 10.3389/fmed.2020.00398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
82 Whitsett M, Ortiz V, Weinberg EM. CON: Liver Transplantation in the Times of COVID-19: Patients with COVID-19 Infection Should not Undergo Liver Transplantation. Clin Liver Dis (Hoboken) 2021;18:233-6. [PMID: 34840724 DOI: 10.1002/cld.1136] [Reference Citation Analysis]
83 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
84 Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, Yada T, Isoda H, Kuwashiro T, Oeda S, Akiyama T, Oza N, Hyogo H, Ono M, Kawaguchi T, Torimura T, Anzai K, Eguchi Y, Takahashi H. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees. Diagnostics (Basel) 2021;11:132. [PMID: 33467114 DOI: 10.3390/diagnostics11010132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Wilke TJ, Fremming BA, Brown BA, Markin NW, Kassel CA. 2020 Clinical Update in Liver Transplantation. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00100-2. [PMID: 33653578 DOI: 10.1053/j.jvca.2021.02.005] [Reference Citation Analysis]
86 Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021;73:890-900. [PMID: 32415860 DOI: 10.1002/hep.31326] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 31.0] [Reference Citation Analysis]
87 Kidson KM, Park J, Charles MK, Omar M, Krajden M, Wright AJ, Hussaini T, Kim PTW, Chung SW, Yoshida EM. Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. Transplant Direct 2021;7:e747. [PMID: 34476292 DOI: 10.1097/TXD.0000000000001210] [Reference Citation Analysis]
88 El Kassas M, Abdelkader H, Medhat MA. COVID-19 in Egypt: Through crisis to adaptation; a gastroenterologist's perspective. Arab J Gastroenterol. 2020;21:207-210. [PMID: 32798187 DOI: 10.1016/j.ajg.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Meunier L, Meszaros M, Pageaux GP. Letter to the Editor: Statins and COVID-19: Efficacy Still to Be Proven. Hepatology 2021;73:875. [PMID: 32767854 DOI: 10.1002/hep.31511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Mohseni M, Albus M, Kaminski A, Harrison MF. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021;13:e14916. [PMID: 34113522 DOI: 10.7759/cureus.14916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Okubo K, Iqbal S, Lizaola-Mayo B, Aqel B, Graf EH, Banacloche JCG, Singer AL, Harbell JW. Liver Transplant in a Polymerase Chain Reaction-Positive COVID-19 Recipient: A Case Report. Transplant Proc 2021;53:2490-4. [PMID: 34446305 DOI: 10.1016/j.transproceed.2021.07.045] [Reference Citation Analysis]
92 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
93 Yadlapati S, Lo KB, DeJoy R, Gul F, Peterson E, Bhargav R, Salacup GF, Pelayo J, Azmaiparashvilli Z, Patarroyo-Aponte G. Prevailing patterns of liver enzymes in patients with COVID-19 infection and association with clinical outcomes. Ann Gastroenterol 2021;34:224-8. [PMID: 33654363 DOI: 10.20524/aog.2021.0573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Aziz H, Filkins A, Kwon YK. Review of COVID-19 Outcomes in Surgical Patients. Am Surg 2020;86:741-5. [PMID: 32683945 DOI: 10.1177/0003134820934395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
95 Siniscalchi A, Vitale G, Morelli MC, Ravaioli M, Laici C, Bianchini A, Del Gaudio M, Conti F, Vizioli L, Cescon M. Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients. Intern Emerg Med. 2020;15:1507-1515. [PMID: 32979193 DOI: 10.1007/s11739-020-02511-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Amor Costa C, Rueda García JL, Rodríguez Gandía MÁ, Fernández Martos R, García-Samaniego Rey J. Fulminant liver failure due to hepatitis B reactivation during the COVID-19 pandemic. Gastroenterol Hepatol 2021:S0210-5705(21)00118-7. [PMID: 33862153 DOI: 10.1016/j.gastrohep.2021.02.019] [Reference Citation Analysis]
98 Lui RN. Safety in endoscopy for patients and healthcare workers during the COVID-19 pandemic. Tech Innov Gastrointest Endosc. 2020;. [PMID: 33103130 DOI: 10.1016/j.tige.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Mirjalili M, Shafiekhani M, Vazin A. Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Ther Clin Risk Manag 2020;16:617-29. [PMID: 32694915 DOI: 10.2147/TCRM.S256246] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
100 Terrabuio DRB, Haddad L, Ducatti L, Nunes Gouveia L, Rocha-Santos V, Ferreira RMT, Darce GF, Cardoso AJA, Carrilho FJ, Andraus W, Abdala E, D Albuquerque LAC. Insights in the approach of long-term liver transplant recipients with COVID-19. Transpl Infect Dis 2021;23:e13424. [PMID: 32702167 DOI: 10.1111/tid.13424] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF;  COVID-LT group. COVID-19 in an international European liver transplant recipient cohort. Gut. 2020;69:1832-1840. [PMID: 32571972 DOI: 10.1136/gutjnl-2020-321923] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
102 Haji Esmaeil Memar E, Mamishi S, Sharifzadeh Ekbatani M, Alimadadi H, Yaghmaei B, Chegini V, Janani S, Mahmoudi S. Fulminant hepatic failure: A rare and devastating manifestation of Coronavirus disease 2019 in an 11-year-old boy. Arch Pediatr 2020;27:502-5. [PMID: 33069564 DOI: 10.1016/j.arcped.2020.09.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
103 Chan SL, Kudo M. Impacts of COVID-19 on Liver Cancers: During and after the Pandemic. Liver Cancer. 2020;9:491-502. [PMID: 33078127 DOI: 10.1159/000510765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
104 Zhao H, Zhou A, Zhou J, Bi X, Yan S, Jin J, Wei W, Li M, Gong C, Chen Q, Luo Z, Li N, Mao R, Chen X, Chen B, Zheng R, Zhao J, Han Y, Li Z, Che X, Tang Y, Sun Y, Huang Z, Zhang Y, Wang X, Zhang Y, Lu Z, Dang X, Song T, Liu C, Yue P, Yan D, Yue A, Zhang R, Luo S, Tan J, Zhang X, Bai X, Zhang X, He M, Xie Y, Wang W, Yang P, Yang Y, Zhang Y, Li Q, Peng T, Wang Z, Chen Y, Shang C, Liang Y, Zhang B, Zhang F, Wang L, Li D, Liu B, Zhu X, Hu Q, Chen M, Xiu D, Xia F, Zhang Y, Zeng Y, Mao Y, Li X, Ba Y, Liang T, Shen F, Liu L, Cai X, Zhou J, Cai J. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey. HPB (Oxford) 2021:S1365-182X(21)00633-X. [PMID: 34400051 DOI: 10.1016/j.hpb.2021.07.002] [Reference Citation Analysis]
105 Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS. Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations. Transplant Proc. 2020;52:2601-2606. [PMID: 32586665 DOI: 10.1016/j.transproceed.2020.05.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
106 Nacif LS, Zanini LY, Waisberg DR, Pinheiro RS, Galvão F, Andraus W, D'Albuquerque LC. COVID-19 in solid organ transplantation patients: A systematic review. Clinics (Sao Paulo) 2020;75:e1983. [PMID: 32520225 DOI: 10.6061/clinics/2020/e1983] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
107 Sharma P, Kumar A, Anikhindi S, Bansal N, Singla V, Shivam K, Arora A. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? J Clin Exp Hepatol 2021;11:484-93. [PMID: 33398223 DOI: 10.1016/j.jceh.2020.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
108 Tan EX, Quek WL, Suryadi, Chahed H, Iyer SG, Jeyaraj PR, Lee GH, Chan A, Cheng S, Hoe J, Tan EK, Chew LY, Fung J, Chen M, Muthiah MD, Huang DQ. Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study. Lancet Reg Health West Pac 2021;16:100262. [PMID: 34514452 DOI: 10.1016/j.lanwpc.2021.100262] [Reference Citation Analysis]
109 Liu Y. Letter to the Editor: Additional Factors to Consider When Studying Liver Injury Indicators and Mortality in COVID-19 Patients. Hepatology 2021;73:868. [PMID: 32619279 DOI: 10.1002/hep.31445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, Loy V, Kim J, Zimmerman MA, Hong JC. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Transplant Proc 2021;53:1132-7. [PMID: 33846012 DOI: 10.1016/j.transproceed.2021.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
111 Govalan R, Luu M, Lauzon M, Kosari K, Ahn JC, Rich NE, Nissen N, Roberts LR, Singal AG, Yang JD. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact. Hepatol Commun 2021. [PMID: 34558830 DOI: 10.1002/hep4.1795] [Reference Citation Analysis]
112 Agopian V, Verna E, Goldberg D. Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center-Level Variability. Liver Transpl. 2020;26:1052-1055. [PMID: 32369251 DOI: 10.1002/lt.25789] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
113 Jaffe A, Schilsky ML, Deshpande R, Batra R. Liver Transplantation in the Time of COVID19: Barriers and Ethical considerations for Management and Next Steps. Hepatol Commun. 2020;. [PMID: 32838103 DOI: 10.1002/hep4.1568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
114 Vinson AJ, Agarwal G, Dai R, Anzalone AJ, Lee SB, French E, Olex A, Madhira V, Mannon RB. COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative. Transplant Direct 2021;7:e775. [PMID: 34646938 DOI: 10.1097/TXD.0000000000001234] [Reference Citation Analysis]
115 Kniepeiss D, Jantscher L, Al-Sharafy S, Sendlhofer G, Schemmer P. Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe. Risk Manag Healthc Policy 2021;14:2421-33. [PMID: 34113196 DOI: 10.2147/RMHP.S286721] [Reference Citation Analysis]
116 Medhat MA, El Kassas M. Letter regarding "High rates of 30-day mortality in patients with cirrhosis and COVID-19". J Hepatol 2020;73:1569-70. [PMID: 32574577 DOI: 10.1016/j.jhep.2020.06.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J Clin Med. 2020;9:3630. [PMID: 33187280 DOI: 10.3390/jcm9113630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
118 Shafiekhani M, Kazemi K, Bahador A, Imanieh MH, Karimzadeh P. Pediatric liver and kidney transplantation in the era of COVID-19: a follow-up study from a tertiary referral center in Iran. BMC Surg. 2021;21:240. [PMID: 33975594 DOI: 10.1186/s12893-021-01226-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
120 Schaefer EAK, Arvind A, Bloom PP, Chung RT. Interrelationship Between Coronavirus Infection and Liver Disease. Clin Liver Dis (Hoboken). 2020;15:175-180. [PMID: 32489653 DOI: 10.1002/cld.967] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
121 Muller X, Tilmans G, Chenevas-Paule Q, Lebossé F, Antonini T, Poinsot D, Rode A, Guichon C, Schmitt Z, Ducerf C, Mohkam K, Lesurtel M, Mabrut JY. Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France. Am J Transplant 2020;20:2989-96. [PMID: 32476233 DOI: 10.1111/ajt.16082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
122 Moghe A, Yakovchenko V, Morgan T, McCurdy H, Scott D, Rozenberg-Ben-Dror K, Rogal S. Strategies to Improve Delivery of Cirrhosis Care. Curr Treat Options Gastroenterol 2021;:1-11. [PMID: 34054289 DOI: 10.1007/s11938-021-00345-y] [Reference Citation Analysis]
123 Oikonomou KG, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A, Bouliaris K, Papamichalis M, Karvouniaris M, Vlachostergios PJ, Skoura AL, Komnos A. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World J Clin Cases 2021; 9(19): 4918-4938 [PMID: 34307544 DOI: 10.12998/wjcc.v9.i19.4918] [Reference Citation Analysis]
124 Putzer G, Martini J, Gasteiger L, Mathis S, Breitkopf R, Hell T, van Enckevort A, Oberhuber R, Öfner D, Schneeberger S. Liver Transplantation Activity in the Eurotransplant Area Is Recovering Slowly During the COVID-19 Crisis. Transplant Direct 2020;6:e611. [PMID: 33134487 DOI: 10.1097/TXD.0000000000001064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Wang Q, Davis PB, Xu R. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine. 2021;31:100688. [PMID: 33521611 DOI: 10.1016/j.eclinm.2020.100688] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
126 Jamir I, Lohia P, Pande RK, Setia R, Singhal AK, Chaudhary A. Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia. Ann Hepatobiliary Pancreat Surg 2020;24:526-32. [PMID: 33234758 DOI: 10.14701/ahbps.2020.24.4.526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
127 Patel S, Parikh C, Verma D, Sundararajan R, Agrawal U, Bheemisetty N, Akku R, Sánchez-Velazco D, Waleed MS. Bowel ischemia in COVID-19: A systematic review. Int J Clin Pract 2021;:e14930. [PMID: 34605117 DOI: 10.1111/ijcp.14930] [Reference Citation Analysis]
128 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
129 Fraser J, Mousley J, Testro A, Smibert OC, Koshy AN. Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis. Transplant Proc 2020;52:2676-83. [PMID: 32891405 DOI: 10.1016/j.transproceed.2020.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
130 Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol 2020;19:627-34. [PMID: 32882393 DOI: 10.1016/j.aohep.2020.08.064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
131 Qazi UA, Sutton J, Farner SC, Bhandari L. Impact of the COVID-19 Pandemic on the Practice of Hand and Upper Extremity Surgeons. Cureus 2020;12:e12072. [PMID: 33489490 DOI: 10.7759/cureus.12072] [Reference Citation Analysis]
132 Abd Elbaset HS, Sultan AM, Montasser IF, Soliman HEM, Elayashy M, Makhlouf NA; Scientific Committee of Ministry of Health (MOH) National Project of Waiting Lists, Egypt. Egyptian protocol for living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic. Egypt Liver J 2021;11:14. [PMID: 34777866 DOI: 10.1186/s43066-020-00074-4] [Reference Citation Analysis]
133 Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. J Clin Gastroenterol. 2021;55:1-11. [PMID: 33230011 DOI: 10.1097/mcg.0000000000001459] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
134 Romagnoli R, Gruttadauria S, Tisone G, Maria Ettorre G, De Carlis L, Martini S, Tandoi F, Trapani S, Saracco M, Luca A, Manzia TM, Visco Comandini U, De Carlis R, Ghisetti V, Cavallo R, Cardillo M, Grossi PA. Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping? Am J Transplant 2021. [PMID: 34467627 DOI: 10.1111/ajt.16823] [Reference Citation Analysis]
135 Kunutsor SK, Laukkanen JA. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis. J Infect 2021;82:159-98. [PMID: 32474033 DOI: 10.1016/j.jinf.2020.05.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
136 Xu J, Han M, Huang C, Liao Y, Wang D, Zhu X, Wang C, Huang J, Guo Z, Chen G, He X. Single-center experience of organ transplant practice during the COVID-19 epidemic. Transpl Int 2021. [PMID: 34152648 DOI: 10.1111/tri.13955] [Reference Citation Analysis]
137 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Donato MF, Invernizzi F, Lampertico P, Rossi G. Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy. Clin Gastroenterol Hepatol 2020;18:2131-2133.e1. [PMID: 32334081 DOI: 10.1016/j.cgh.2020.04.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
139 Bhatti ABH, Nazish M, Khan NY, Manan F, Zia HH, Ilyas A, Ishtiaq W, Khan NA. Living Donor Liver Transplantation During the COVID-19 Pandemic: an Evolving Challenge. J Gastrointest Surg 2021. [PMID: 34131867 DOI: 10.1007/s11605-021-05057-3] [Reference Citation Analysis]
140 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
141 Bellini MI, Fresilli D, Lauro A, Mennini G, Rossi M, Catalano C, D’andrea V, Cantisani V, Kaiser G. Liver Transplant Imaging prior to and during the COVID-19 Pandemic. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/7768383] [Reference Citation Analysis]
142 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
143 Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother 2021;133:111064. [PMID: 33378966 DOI: 10.1016/j.biopha.2020.111064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
144 Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL;  Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020;5:776-787. [PMID: 32585136 DOI: 10.1016/s2468-1253(20)30190-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
145 Abe K, Yamamoto T, Matsumoto K, Kikuchi K, Miura R, Tachizawa N, Asaoka Y, Takezawa T, Matsunaga N, Obi S, Tanaka A. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population. Intern Med. 2020;59:2353-2358. [PMID: 32999264 DOI: 10.2169/internalmedicine.5777-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
146 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
147 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
148 Pomej K, Scheiner B, Hartl L, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. PLoS One 2021;16:e0256544. [PMID: 34437610 DOI: 10.1371/journal.pone.0256544] [Reference Citation Analysis]
149 APASL Covid-19 Task Force. Lau G, Sharma M. Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations. Hepatol Int. 2020;14:415-428. [PMID: 32447721 DOI: 10.1007/s12072-020-10054-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
150 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Macciò L, Meneguzzi C, Mioni D, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Caio G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA). Addict Biol 2021;:e13090. [PMID: 34532923 DOI: 10.1111/adb.13090] [Reference Citation Analysis]
151 Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M. Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic. Rev Gastroenterol Mex (Engl Ed) 2020;85:312-20. [PMID: 32620315 DOI: 10.1016/j.rgmx.2020.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Hu X, Sun L, Guo Z, Wu C, Yu X, Li J. Management of COVID-19 Patients with Chronic Liver Diseases and Liver Transplants. Ann Hepatol 2021;:100653. [PMID: 34929350 DOI: 10.1016/j.aohep.2021.100653] [Reference Citation Analysis]
153 Reddy MS, Hakeem AR, Klair T, Marcon F, Mathur A, Samstein B, Mohanka R, Mathur SK, Prachalias A, Menon KV, Muiesan P, Rela M, Emond JC. Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels. Transplantation 2020;104:2234-43. [DOI: 10.1097/tp.0000000000003416] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
154 Ahmed M. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. Gastroenterology Res 2020;13:89-95. [PMID: 32655724 DOI: 10.14740/gr1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Gupta S, Sudhindran S, Saraf N, Vijai A, Swaminathan S, Panackel C, Mehta NN, Varghese J, Singh S, Reddy MS, Viswanathan MS, Bhangui P, Mohanka R, Asthana S, Rohatgi S. Liver Transplant Society of India Guidelines for Liver Transplant during COVID-19 times. J Clin Exp Hepatol 2021. [PMID: 34429571 DOI: 10.1016/j.jceh.2021.08.012] [Reference Citation Analysis]
156 Guarino M, Cossiga V, Fiorentino A, Pontillo G, Morisco F. Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study. J Med Internet Res 2020;22:e20874. [PMID: 32896833 DOI: 10.2196/20874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
157 Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
158 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
160 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Nayak B, Lal G, Kumar S, Das CJ, Saraya A, Shalimar. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. Front Cell Infect Microbiol 2021;11:753249. [PMID: 34760721 DOI: 10.3389/fcimb.2021.753249] [Reference Citation Analysis]
162 Boraschi P, Giugliano L, Mercogliano G, Donati F, Romano S, Neri E. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol 2021; 27(26): 4143-4159 [PMID: 34326615 DOI: 10.3748/wjg.v27.i26.4143] [Reference Citation Analysis]
163 Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: Its impact on liver disease and liver transplantation. World J Gastroenterol 2020; 26(22): 2987-2999 [PMID: 32587443 DOI: 10.3748/wjg.v26.i22.2987] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
164 Cho JY, Lee YS, Kim SS, Song DS, Lee JH, Kim JH. Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. Clin Mol Hepatol 2021;27:515-23. [PMID: 34530524 DOI: 10.3350/cmh.2021.0293] [Reference Citation Analysis]
165 Niknam R, Malek-Hosseini SA, Hashemieh SS, Dehghani M. COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature. Int Med Case Rep J 2020;13:317-21. [PMID: 32801943 DOI: 10.2147/IMCRJ.S265910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
166 Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, Cunha L, Spearman CW, Sonderup MW, Kateera F. Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2020;5:634-636. [PMID: 32553140 DOI: 10.1016/s2468-1253(20)30155-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
167 Mohammed A, Paranji N, Chen PH, Niu B. COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review. J Clin Gastroenterol 2021;55:187-94. [PMID: 33394628 DOI: 10.1097/MCG.0000000000001481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
168 Sharma R, Pinato DJ. Management of Hepatocellular Cancer in the time of SARS-CoV-2. Liver Int 2020;40:1823-5. [PMID: 32416633 DOI: 10.1111/liv.14517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
169 Cadranel JF, Reboux N, Nousbaum JB. COVID-19: an emergent cause of liver injury? Eur J Gastroenterol Hepatol. 2021;33:1-3. [PMID: 32639418 DOI: 10.1097/meg.0000000000001824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Rosenblatt R, Verna EC. COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients. Clin Liver Dis (Hoboken). 2020;15:200-203. [PMID: 32537136 DOI: 10.1002/cld.968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
171 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Perisetti A, Gajendran M, Mann R, Elhanafi S, Goyal H. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations. Dis Mon. 2020;66:101064. [PMID: 32807535 DOI: 10.1016/j.disamonth.2020.101064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
173 Pokorska-Śpiewak M, Śpiewak M. Management of hepatitis C in children and adolescents during COVID-19 pandemic. World J Hepatol 2020; 12(8): 485-492 [PMID: 32952875 DOI: 10.4254/wjh.v12.i8.485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
174 Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Gastroenterol Hepatol 2020;43:472-80. [PMID: 32727662 DOI: 10.1016/j.gastrohep.2020.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
175 Kabaçam G, Dayangaç M, Üçbilek E, Erçin CN, Günsar F, Akyıldız M, Akarsu M, Demir M, Kaymakoğlu S, Karasu Z, İdilman R. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turk J Gastroenterol 2020;31:348-55. [PMID: 32519953 DOI: 10.5152/tjg.2020.20413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
177 Ismail Z, Aborode AT, Oyeyemi AA, Khan H, Hasan MM, Saha A, Akah B. Impact of COVID-19 pandemic on viral hepatitis in Africa: Challenges and way forward. Int J Health Plann Manage 2021. [PMID: 34462959 DOI: 10.1002/hpm.3317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Zeng G, Gill US, Kennedy PTF. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis. Gut 2020;69:1907-12. [PMID: 32451325 DOI: 10.1136/gutjnl-2020-321627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
179 Pearson MM, Limaye AP, Biggins SW. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19. Gastroenterology. 2021;160:1012-1013. [PMID: 33387518 DOI: 10.1053/j.gastro.2020.12.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L. Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol 2021; 27(10): 928-938 [PMID: 33776364 DOI: 10.3748/wjg.v27.i10.928] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
181 Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:431. [PMID: 32793616 DOI: 10.3389/fmed.2020.00431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
182 Kushner T, Cafardi J. Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Clin Liver Dis (Hoboken). 2020;15:195-199. [PMID: 32537135 DOI: 10.1002/cld.974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
183 Rehman ST, Rehman H, Abid S. Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C. World J Hepatol 2021; 13(7): 781-789 [PMID: 34367499 DOI: 10.4254/wjh.v13.i7.781] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Mao R, Rieder F, Ben-Horin S, Kaplan GG, Ng SC, Wong GL, Ghosh S, Chen MH. Implications of COVID-19 for patients with pre-existing digestive diseases: an update. Lancet Gastroenterol Hepatol. 2021;6:258-260. [PMID: 33539813 DOI: 10.1016/s2468-1253(21)00025-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
185 Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:533-539. [PMID: 32837096 DOI: 10.1016/j.jceh.2020.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
186 Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, Li M, Chung H, Al Balakosy A, Alqassieh A, Fülöp T, Rizzo V, Daoud A, Soliman KM. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021; 9(23): 6608-6623 [PMID: 34447809 DOI: 10.12998/wjcc.v9.i23.6608] [Reference Citation Analysis]
187 Miarons M, Larrosa-García M, García-García S, Los-Arcos I, Moreso F, Berastegui C, Castells L, Pérez-Hoyos S, Varela J, Pau-Parra A, Varón-Galcera C, Parramon-Teixidó CJ, Martínez-Casanova J, Domènech L, García-Ortega P, Sánchez-Sancho P, Alonso-Martínez C, Gómez-Ganda L, Roch-Santed M, Gracia-Moya A, Del-Rio-Gutiérrez JM, Guillén-Del-Castillo A, Sans-Pola C, Antón A, Montoro B, Gorgas-Torner MQ; Vall d’Hebron COVID-19 Working Group. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Transplantation 2021;105:138-50. [PMID: 32941394 DOI: 10.1097/TP.0000000000003460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]
188 Becchetti C, Broekhoven AGC, Dahlqvist G, Fraga M, Zambelli MF, Ciccarelli O, Saouli AC, Trizzino A, Banz V, Dufour JF, Roukens AHE, Torres Morales SP, Myeni SK, Kikkert M, Feltkamp MCW, Coenraad MJ. Humoral response to SARS-CoV-2 infection among liver transplant recipients. Gut 2022:gutjnl-2021-326609. [PMID: 34987065 DOI: 10.1136/gutjnl-2021-326609] [Reference Citation Analysis]
189 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
190 Wood RM. Modelling the impact of COVID-19 on elective waiting times. Journal of Simulation. [DOI: 10.1080/17477778.2020.1764876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
191 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
192 Di Sessa A, Lanzaro F, Zarrilli S, Picone V, Guarino S, Miraglia del Giudice E, Marzuillo P. COVID-19 and pediatric fatty liver disease: Is there interplay? World J Gastroenterol 2021; 27(22): 3064-3072 [PMID: 34168408 DOI: 10.3748/wjg.v27.i22.3064] [Reference Citation Analysis]
193 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
194 Dipasquale V, Passanisi S, Cucinotta U, Cascio A, Romano C. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital J Pediatr 2021;47:71. [PMID: 33761992 DOI: 10.1186/s13052-021-01020-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Inchingolo R, Acquafredda F, Tedeschi M, Laera L, Surico G, Surgo A, Fiorentino A, Spiliopoulos S, de’Angelis N, Memeo R. Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic. World J Gastroenterol 2021; 27(25): 3780-3789 [PMID: 34321843 DOI: 10.3748/wjg.v27.i25.3780] [Reference Citation Analysis]
196 Chaubal G, Hatimi H, Nanavati A, Deshpande A, Andankar P, Biradar V, Gupte P, Hanchnale P, Bhalerao S, Tambe S. Pediatric living donor intestine transplant following an atypical complication of COVID-19: A unique case report from India. Am J Transplant 2021. [PMID: 34390165 DOI: 10.1111/ajt.16798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Bollipo S, Kapuria D, Rabiee A, Ben-Yakov G, Lui RN, Lee HW, Kumar G, Siau K, Turnes J, Dhanasekaran R. One world, one pandemic, many guidelines: management of liver diseases during COVID-19. Gut. 2020;69:1369-1372. [PMID: 32499304 DOI: 10.1136/gutjnl-2020-321553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
198 Ray U, Aziz F, Shankar A, Biswas AS, Chakraborty A. COVID-19: The Impact in Oncology Care. SN Compr Clin Med 2020;:1-10. [PMID: 33134842 DOI: 10.1007/s42399-020-00592-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Sagnelli C, Pisaturo M, Curatolo C, Codella AV, Coppola N, Sagnelli E. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic. World J Gastroenterol 2021; 27(42): 7271-7284 [PMID: 34876788 DOI: 10.3748/wjg.v27.i42.7271] [Reference Citation Analysis]
200 Shafiekhani M, Shahabinezhad F, Niknam T, Tara SA, Haem E, Mardani P, Zare Z, Jafarian S, Mirzad Jahromi K, Arabsheybani S, Moeini YS, Alavi J, Jalali SS, Salimi M, Shahriarirad R, Malekhosseini SA. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virol J 2021;18:228. [PMID: 34809657 DOI: 10.1186/s12985-021-01700-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Tacke F, Cornberg M, Sterneck M, Trebicka J, Settmacher U, Bechstein WO, Berg T; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), vertreten durch Frank Tacke, Markus Cornberg, Martina Sterneck, Jonel Trebicka, Thomas Berg., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), vertreten durch Wolf Bechstein., Deutsche Transplantationsgesellschaft (DTG), vertreten durch Utz Settmacher., Die Leitlinie wird von der Deutschen Gesellschaft für Pneumologie (DGP) unterstützt. S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21. Z Gastroenterol 2021;59:345-59. [PMID: 33845500 DOI: 10.1055/a-1372-5595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic. Singapore Med J 2020;61:619-23. [PMID: 32349198 DOI: 10.11622/smedj.2020069] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
203 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
204 Frager SZ, Szymanski J, Schwartz JM, Massoumi HS, Kinkhabwala M, Wolkoff AW. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis. Hepatol Commun. 2020;5:424-433. [PMID: 33681677 DOI: 10.1002/hep4.1648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
205 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Pawlowska J, Lebensztejn DM, Jankowska I. Coronavirus Disease 2019-Liver Injury-Literature Review and Guidelines Based on the Recommendations of Hepatological Societies. Pediatr Gastroenterol Hepatol Nutr. 2021;24:119-126. [PMID: 33833967 DOI: 10.5223/pghn.2021.24.2.119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol. 2020;55:1098-1106. [PMID: 32776161 DOI: 10.1007/s00535-020-01717-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
208 Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol. 2021;74:168-184. [PMID: 33038433 DOI: 10.1016/j.jhep.2020.09.031] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 29.5] [Reference Citation Analysis]
209 Dongiovanni P, Meroni M, Longo M, Fracanzani AL. MAFLD in COVID-19 patients: an insidious enemy. Expert Review of Gastroenterology & Hepatology 2020;14:867-72. [DOI: 10.1080/17474124.2020.1801417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
210 Boretti A, Banik B. Modulation of Covid-19 cytokine storm by tocilizumab. J Med Virol 2021. [PMID: 34617604 DOI: 10.1002/jmv.27380] [Reference Citation Analysis]
211 Aguila EJT, Cua IHY, Dumagpi JEL, Francisco CPD, Raymundo NTV, Sy-Janairo MLL, Cabral-Prodigalidad PAI, Lontok MAD. COVID-19 and its effects on the digestive system and endoscopy practice. JGH Open. 2020;4:324-331. [PMID: 32514432 DOI: 10.1002/jgh3.12358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
212 Goh KL, Chuah KH. COVID-19 and the digestive system: More than just a "flu". JGH Open. 2020;4:318-319. [PMID: 32514430 DOI: 10.1002/jgh3.12364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Giovinazzo F, Avolio AW, Galiandro F, Vitale A, Dalla Riva GV, Biancofiore G, Sharma S, Muiesan P, Agnes S, Burra P. Solid Organ Transplantation During COVID-19 Pandemic: An International Web-based Survey on Resources' Allocation. Transplant Direct 2021;7:e669. [PMID: 34113712 DOI: 10.1097/TXD.0000000000001115] [Reference Citation Analysis]
214 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
215 Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R;  COLD Consortium. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology. 2020;72:1900-1911. [PMID: 32964510 DOI: 10.1002/hep.31574] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
216 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
217 Lau G, Ward JW. Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic. Clin Liver Dis (Hoboken). 2020;15:204-209. [PMID: 32489655 DOI: 10.1002/cld.972] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
218 Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-33. [PMID: 34475732 DOI: 10.20524/aog.2021.0628] [Reference Citation Analysis]
219 Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med 2021;10:4015. [PMID: 34501463 DOI: 10.3390/jcm10174015] [Reference Citation Analysis]
220 Gupta R, Gupta J, Ammar H. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol 2021;14:932-46. [PMID: 33928515 DOI: 10.1007/s12328-021-01424-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS 4th, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C;  contributing Members and Collaborators of ERN RARE-LIVER/COVID-Hep/SECURE-Cirrhosis; Moon AM, Webb GJ, Lohse AW. SARS-CoV-2 infection in patients with autoimmune hepatitis. J Hepatol. 2021;74:1335-1343. [PMID: 33508378 DOI: 10.1016/j.jhep.2021.01.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
222 Ganne-Carrié N, Fontaine H, Dumortier J, Boursier J, Bureau C, Leroy V, Bourlière M; AFEF, French Association for the Study of the Liver. Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic. Clin Res Hepatol Gastroenterol 2020;44:275-81. [PMID: 32360055 DOI: 10.1016/j.clinre.2020.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
223 Patel P, Pillai A. Liver Transplantation Services During the Time of COVID-19. J Clin Transl Hepatol 2021;9:587-91. [PMID: 34447689 DOI: 10.14218/JCTH.2021.00095] [Reference Citation Analysis]
224 Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612-620. [PMID: 32725453 DOI: 10.1007/s12072-020-10078-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
225 Almas T, Ehtesham M, Khedro T, Haadi A, Nabeel AR, Hussain S, Alsufyani R, Al-Awaid AH, Sclair S, Mansoor E. The many faces of coronavirus disease 2019: COVID-19 and the liver. Ann Med Surg (Lond) 2021;64:102224. [PMID: 33747505 DOI: 10.1016/j.amsu.2021.102224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]